rs9303326
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_021078.3(KAT2A):c.2155T>C(p.Leu719Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00273 in 1,613,928 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 28 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 27 hom. )
Consequence
KAT2A
NM_021078.3 synonymous
NM_021078.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.771
Genes affected
KAT2A (HGNC:4201): (lysine acetyltransferase 2A) KAT2A, or GCN5, is a histone acetyltransferase (HAT) that functions primarily as a transcriptional activator. It also functions as a repressor of NF-kappa-B (see MIM 164011) by promoting ubiquitination of the NF-kappa-B subunit RELA (MIM 164014) in a HAT-independent manner (Mao et al., 2009 [PubMed 19339690]).[supplied by OMIM, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 17-42114374-A-G is Benign according to our data. Variant chr17-42114374-A-G is described in ClinVar as [Benign]. Clinvar id is 773591.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.771 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00997 (1517/152108) while in subpopulation AFR AF= 0.033 (1369/41464). AF 95% confidence interval is 0.0316. There are 28 homozygotes in gnomad4. There are 722 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1517 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KAT2A | NM_021078.3 | c.2155T>C | p.Leu719Leu | synonymous_variant | Exon 15 of 18 | ENST00000225916.10 | NP_066564.2 | |
KAT2A | NM_001376227.1 | c.2158T>C | p.Leu720Leu | synonymous_variant | Exon 15 of 18 | NP_001363156.1 | ||
KAT2A | XM_006721818.5 | c.1075T>C | p.Leu359Leu | synonymous_variant | Exon 10 of 13 | XP_006721881.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00997 AC: 1516AN: 151990Hom.: 28 Cov.: 32
GnomAD3 genomes
AF:
AC:
1516
AN:
151990
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00319 AC: 802AN: 251450Hom.: 8 AF XY: 0.00257 AC XY: 349AN XY: 135896
GnomAD3 exomes
AF:
AC:
802
AN:
251450
Hom.:
AF XY:
AC XY:
349
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00197 AC: 2885AN: 1461820Hom.: 27 Cov.: 32 AF XY: 0.00181 AC XY: 1314AN XY: 727220
GnomAD4 exome
AF:
AC:
2885
AN:
1461820
Hom.:
Cov.:
32
AF XY:
AC XY:
1314
AN XY:
727220
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00997 AC: 1517AN: 152108Hom.: 28 Cov.: 32 AF XY: 0.00971 AC XY: 722AN XY: 74382
GnomAD4 genome
AF:
AC:
1517
AN:
152108
Hom.:
Cov.:
32
AF XY:
AC XY:
722
AN XY:
74382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Apr 04, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at